920 related articles for article (PubMed ID: 21810889)
1. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.
Cummings JL; Henchcliffe C; Schaier S; Simuni T; Waxman A; Kemp P
Brain; 2011 Nov; 134(Pt 11):3146-66. PubMed ID: 21810889
[TBL] [Abstract][Full Text] [Related]
2. Nigrostriatal dopamine terminal imaging with dopamine transporter SPECT: an update.
Tatsch K; Poepperl G
J Nucl Med; 2013 Aug; 54(8):1331-8. PubMed ID: 23864718
[TBL] [Abstract][Full Text] [Related]
3. [Study of the pre and post-synaptic dopaminergic system by DaTSCAN/IBZM SPECT in the differential diagnosis of parkinsonism in 75 patients].
Vaamonde J; Ibáñez R; García AM; Poblete V
Neurologia; 2004; 19(6):292-300. PubMed ID: 15199417
[TBL] [Abstract][Full Text] [Related]
4. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
5. [DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].
Vaamonde-Gamo J; Flores-Barragán JM; Ibáñez R; Gudín M; Hernández A
Rev Neurol; 2005 Sep 1-15; 41(5):276-9. PubMed ID: 16138284
[TBL] [Abstract][Full Text] [Related]
6. Role of dopamine transporter imaging in routine clinical practice.
Marshall V; Grosset D
Mov Disord; 2003 Dec; 18(12):1415-23. PubMed ID: 14673877
[TBL] [Abstract][Full Text] [Related]
7. Dementia with Lewy bodies versus Alzheimer's disease: role of dopamine transporter imaging.
Costa DC; Walker Z; Walker RW; Fontes FR
Mov Disord; 2003 Oct; 18 Suppl 7():S34-8. PubMed ID: 14531044
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.
King AE; Mintz J; Royall DR
Mov Disord; 2011 Jun; 26(7):1218-24. PubMed ID: 21480373
[TBL] [Abstract][Full Text] [Related]
9. Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study.
Nicastro N; Burkhard PR; Garibotto V
J Neurol Sci; 2018 Feb; 385():17-21. PubMed ID: 29406901
[TBL] [Abstract][Full Text] [Related]
10. A new visual rating scale for Ioflupane imaging in Lewy body disease.
Lloyd JJ; Petrides G; Donaghy PC; Colloby SJ; Attems J; O'Brien JT; Roberts G; Thomas AJ
Neuroimage Clin; 2018; 20():823-829. PubMed ID: 30268991
[TBL] [Abstract][Full Text] [Related]
11. PD and DLB: Brain imaging in Parkinson's disease and dementia with Lewy bodies.
Berman SB; Miller-Patterson C
Prog Mol Biol Transl Sci; 2019; 165():167-185. PubMed ID: 31481162
[TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice.
Ba F; Martin WR
Parkinsonism Relat Disord; 2015 Feb; 21(2):87-94. PubMed ID: 25487733
[TBL] [Abstract][Full Text] [Related]
13. In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.
Nikolaus S; Antke C; Müller HW
Behav Brain Res; 2009 Dec; 204(1):1-31. PubMed ID: 19523490
[TBL] [Abstract][Full Text] [Related]
14. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.
Iannaccone S; Cerami C; Alessio M; Garibotto V; Panzacchi A; Olivieri S; Gelsomino G; Moresco RM; Perani D
Parkinsonism Relat Disord; 2013 Jan; 19(1):47-52. PubMed ID: 22841687
[TBL] [Abstract][Full Text] [Related]
15. Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders.
Wallert ED; van de Giessen E; Knol RJJ; Beudel M; de Bie RMA; Booij J
J Nucl Med; 2022 Jun; 63(Suppl 1):27S-32S. PubMed ID: 35649651
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool.
Nicastro N; Nencha U; Burkhard PR; Garibotto V
J Neurochem; 2023 Feb; 164(3):346-363. PubMed ID: 34935143
[TBL] [Abstract][Full Text] [Related]
17. [Nuclear neuroimaging of dopamine transporter in Parkinsonism--role in routine clinical practice].
Cohenpour M; Golan H
Harefuah; 2007 Sep; 146(9):698-702, 733. PubMed ID: 17969308
[TBL] [Abstract][Full Text] [Related]
18. Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.
Kraemmer J; Kovacs GG; Perju-Dumbrava L; Pirker S; Traub-Weidinger T; Pirker W
Mov Disord; 2014 Dec; 29(14):1767-73. PubMed ID: 25048738
[TBL] [Abstract][Full Text] [Related]
19. The diagnosis of Parkinson's disease.
Tolosa E; Wenning G; Poewe W
Lancet Neurol; 2006 Jan; 5(1):75-86. PubMed ID: 16361025
[TBL] [Abstract][Full Text] [Related]
20. Imaging Familial and Sporadic Neurodegenerative Disorders Associated with Parkinsonism.
Brooks DJ
Neurotherapeutics; 2021 Apr; 18(2):753-771. PubMed ID: 33432494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
